1
OnsetLab
Shares tags: ai
AI Tool
EVEscape Review
EVEscape is an AI tool that predicts the likelihood of antibody escape for viral mutations, aiding in the design of vaccines and therapies.
1Developed by researchers at Harvard Medical School and the University of Oxford.
2Featured in a *Nature* study on October 11, 2023, for its predictive capabilities.
3Achieves over 85% prediction accuracy in retrospective analysis for SARS-CoV-2 mutation forecasting.
4Provides biweekly rankings of new SARS-CoV-2 variants to organizations such as the World Health Organization (WHO).
⚡
EVEscape at a Glance
</>Embed "Featured on Stork" Badge▼
<a href="https://www.stork.ai/en/evescape" target="_blank" rel="noopener noreferrer"><img src="https://www.stork.ai/api/badge/evescape?style=dark" alt="EVEscape - Featured on Stork.ai" height="36" /></a>
[](https://www.stork.ai/en/evescape)
overview
What is EVEscape?
EVEscape is an AI tool developed by researchers at Harvard Medical School and the University of Oxford that enables researchers, vaccine developers, therapeutic designers, public health organizations, and the viral surveillance community to predict the likelihood of antibody escape for viral mutations. It aids in anticipating new viral variants before their emergence, informing the development of more effective vaccines and therapies. The tool forecasts the likelihood of viral antibody escape by combining a deep-learning model of evolutionary viral sequences with detailed biological and structural information about the virus. It leverages extensive historical viral sequence data and simulates viral protein evolution to predict potential mutation trajectories under immune pressure. EVEscape is suitable for both early-stage virus outbreaks and continuous assessment of novel variants, as it does not rely on real-time virus information or the availability of relevant antibodies. Its ability to effectively capture pivotal mutations extends to less-studied viruses with pandemic potential, such as Lassa and Nipah viruses, alongside more common ones like HIV and influenza.
quick facts
Quick Facts
| Attribute | Value |
|---|---|
| Developer | Harvard Medical School and University of Oxford |
| Business Model | Freemium |
| Pricing | Freemium: Free tier available |
| Platforms | Web |
| API Available | No |
features
Key Features of EVEscape
EVEscape provides a suite of features designed to predict viral evolution and inform public health strategies.
- 1Predicts the likelihood of antibody escape for viral mutations.
- 2Aids in the design of vaccines by identifying concerning mutations.
- 3Aids in the design of therapies to counter immune-evading variants.
- 4Utilizes evolutionary information from extensive viral sequence data.
- 5Incorporates biological information and structural details of viruses.
- 6Computes the likelihood of antibody escape for specific viral mutations.
- 7Flags potentially concerning viral strains from their emergence.
- 8Forecasts potential variants to flagged strains and existing Variants of Concern.
- 9Provides continually updated escape scores for current viral strains.
- 10Predicts future mutations based on evolutionary trajectories.
use cases
Who Should Use EVEscape?
EVEscape is designed for scientific and public health professionals requiring advanced predictive capabilities for viral evolution and immune escape.
- 1**Researchers:** To forecast viral variants and understand mutation trajectories under immune pressure.
- 2**Vaccine Developers:** To guide the development of 'variant-proof' vaccines by identifying concerning mutations proactively.
- 3**Therapeutic Designers:** To inform the creation of more effective treatments against evolving viral strains.
- 4**Public Health Organizations:** For pandemic preparedness, early warnings for emerging viral outbreaks, and assessing the threat level of new strains.
- 5**Viral Surveillance Community:** To monitor and assess the escape potential of current and future viral strains, including less-studied pathogens.
pricing
EVEscape Pricing & Plans
EVEscape operates on a freemium model, providing a free tier for users to access its core functionalities. Specific details regarding paid tiers or advanced features, such as enhanced data access or specialized analyses, are not publicly disclosed beyond the general freemium availability.
- 1Freemium: Free tier available
competitors
EVEscape vs Competitors
EVEscape distinguishes itself from other tools by its early prediction capability, data independence, and generalizability across diverse virus types.
1
EVE-Vax↗
EVE-Vax is an AI tool that designs synthetic viral proteins to mimic future immune-evading variants, enabling proactive vaccine development.
EVE-Vax builds upon the EVEscape framework, extending its predictive capabilities into the direct design of vaccine antigens, whereas EVEscape primarily focuses on predicting escape likelihood. Both tools originate from the same research group.
2
VaxSeer↗
VaxSeer uses machine learning to predict dominant flu strains and identify the most protective vaccine candidates months in advance.
While EVEscape offers a general method for virus escape prediction across various viruses, VaxSeer is specifically tailored for influenza vaccine strain selection, aiming to improve accuracy and reduce guesswork in annual vaccine decisions.
3
Multi-task learning framework for antibody escape prediction (Gross & Sharan)↗
This computational framework utilizes systematic mutation screens in the receptor binding domain of the viral Spike protein and multi-task learning to predict escape and binding properties for multiple antibodies simultaneously.
This framework is a research-oriented computational approach specifically for SARS-CoV-2 antibody escape, similar in goal to EVEscape but potentially more focused on the mechanistic analysis of mutation screens rather than broad evolutionary forecasting.
4
AbMap↗
AbMap is a computational technique that uses large language models to accurately predict antibody structures and their binding strength to antigens, particularly focusing on hypervariable regions.
While EVEscape predicts viral escape mutations, AbMap focuses on the antibody side, predicting antibody structures and binding to identify effective neutralizing antibodies, which is complementary but distinct from directly predicting viral escape likelihood.
❓
Frequently Asked Questions
+What is EVEscape?
EVEscape is an AI tool developed by researchers at Harvard Medical School and the University of Oxford that enables researchers, vaccine developers, therapeutic designers, public health organizations, and the viral surveillance community to predict the likelihood of antibody escape for viral mutations. It aids in anticipating new viral variants before their emergence, informing the development of more effective vaccines and therapies.
+Is EVEscape free?
Yes, EVEscape operates on a freemium model, offering a free tier for users. Specific details regarding potential paid tiers or advanced features are not publicly available.
+What are the main features of EVEscape?
EVEscape's main features include predicting the likelihood of antibody escape for viral mutations, aiding in vaccine and therapy design, using evolutionary and biological information, flagging concerning viral strains, forecasting potential variants, and providing continually updated escape scores and future mutation predictions.
+Who should use EVEscape?
EVEscape is intended for researchers, vaccine developers, therapeutic designers, public health organizations, and the viral surveillance community. It supports forecasting viral variants, guiding vaccine and therapy development, and enhancing pandemic preparedness.
+How does EVEscape compare to alternatives?
EVEscape offers early prediction capabilities and generalizability across diverse viruses, unlike experimental methods that are resource-intensive. It differs from EVE-Vax by focusing on prediction rather than direct antigen design, from VaxSeer by being general-purpose instead of influenza-specific, and from AbMap by predicting viral escape mutations rather than antibody structures.